TY - BOOK ID - 8507509 TI - Challenges and Opportunities for Respiratory Syncytial Virus Vaccines AU - Anderson, Larry J. AU - Graham, Barney S. PY - 2013 SN - 364238918X 3642389198 PB - Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, DB - UniCat KW - Emerging infectious diseases. KW - Medicine. KW - Vaccines. KW - Models, Animal KW - Pneumovirus Infections KW - Models, Biological KW - Animal Diseases KW - Viral Vaccines KW - Investigative Techniques KW - Vaccines KW - Paramyxoviridae Infections KW - Models, Theoretical KW - Diseases KW - Biological Products KW - Analytical, Diagnostic and Therapeutic Techniques and Equipment KW - Mononegavirales Infections KW - RNA Virus Infections KW - Complex Mixtures KW - Chemicals and Drugs KW - Virus Diseases KW - Disease Models, Animal KW - Respiratory Syncytial Virus Vaccines KW - Respiratory Syncytial Virus Infections KW - Biology KW - Health & Biological Sciences KW - Microbiology & Immunology KW - Respiratory syncytial virus KW - Respiratory organs KW - Vaccination. KW - Diseases. KW - Respiratory diseases KW - Emerging infections KW - New infectious diseases KW - Re-emerging infectious diseases KW - Reemerging infectious diseases KW - Pseudomyxoviruses KW - Virology. KW - Infectious diseases. KW - Pediatrics. KW - Biomedicine. KW - Vaccine. KW - Infectious Diseases. KW - Pneumology/Respiratory System. KW - Biologicals KW - Paediatrics KW - Pediatric medicine KW - Medicine KW - Children KW - Microbiology KW - Clinical sciences KW - Medical profession KW - Human biology KW - Life sciences KW - Medical sciences KW - Pathology KW - Physicians KW - Health and hygiene KW - Communicable diseases KW - Paramyxoviruses KW - Medical virology. KW - Pneumology. KW - Medical microbiology KW - Virology KW - Virus diseases KW - Respiratory organs—Diseases. KW - Pharmacology. KW - Human beings KW - Illness KW - Illnesses KW - Morbidity KW - Sickness KW - Sicknesses KW - Epidemiology KW - Health KW - Sick KW - Drug effects KW - Medical pharmacology KW - Chemicals KW - Chemotherapy KW - Drugs KW - Pharmacy KW - Physiological effect UR - https://www.unicat.be/uniCat?func=search&query=sysid:8507509 AB - Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine. ER -